Cargando…
Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets
Chronic hepatitis viral infection, alcoholic intoxication, and obesity cause liver fibrosis, which progresses to decompensated liver cirrhosis, a disease for which medical demands cannot be met. Since there are currently no approved anti-fibrotic therapies for established liver fibrosis, the develop...
Autores principales: | Itaba, Noriko, Kono, Yohei, Watanabe, Kaori, Yokobata, Tsuyoshi, Oka, Hiroyuki, Osaki, Mitsuhiko, Kakuta, Hiroki, Morimoto, Minoru, Shiota, Goshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497888/ https://www.ncbi.nlm.nih.gov/pubmed/31048740 http://dx.doi.org/10.1038/s41598-019-43298-0 |
Ejemplares similares
-
Hepatic cell sheets engineered from human mesenchymal stem cells with a single small molecule compound IC-2 ameliorate acute liver injury in mice
por: Itaba, Noriko, et al.
Publicado: (2018) -
Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice
por: Itaba, Noriko, et al.
Publicado: (2015) -
Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice
por: Fukushima, Kenji, et al.
Publicado: (2021) -
A report of the 18th congress of the Japanese Society for Regenerative Medicine
por: Itaba, Noriko, et al.
Publicado: (2020) -
Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells
por: Itaba, Noriko, et al.
Publicado: (2015)